[go: up one dir, main page]

WO2014020446A2 - Hydroxyapatite coating process using microwave technology - Google Patents

Hydroxyapatite coating process using microwave technology Download PDF

Info

Publication number
WO2014020446A2
WO2014020446A2 PCT/IB2013/002181 IB2013002181W WO2014020446A2 WO 2014020446 A2 WO2014020446 A2 WO 2014020446A2 IB 2013002181 W IB2013002181 W IB 2013002181W WO 2014020446 A2 WO2014020446 A2 WO 2014020446A2
Authority
WO
WIPO (PCT)
Prior art keywords
substrate
coating
hydroxyapatite
solution
heating
Prior art date
Application number
PCT/IB2013/002181
Other languages
French (fr)
Other versions
WO2014020446A3 (en
Inventor
Mirjam LILJA
Ulrika BROHEDE
Original Assignee
Sandvik Intellectual Property Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandvik Intellectual Property Ab filed Critical Sandvik Intellectual Property Ab
Publication of WO2014020446A2 publication Critical patent/WO2014020446A2/en
Publication of WO2014020446A3 publication Critical patent/WO2014020446A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C18/00Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
    • C23C18/02Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
    • C23C18/12Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
    • C23C18/1204Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material inorganic material, e.g. non-oxide and non-metallic such as sulfides, nitrides based compounds
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C18/00Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
    • C23C18/02Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
    • C23C18/12Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
    • C23C18/1229Composition of the substrate
    • C23C18/1245Inorganic substrates other than metallic
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C18/00Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
    • C23C18/02Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
    • C23C18/12Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
    • C23C18/125Process of deposition of the inorganic material
    • C23C18/1283Control of temperature, e.g. gradual temperature increase, modulation of temperature
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C28/00Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
    • C23C28/04Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C28/00Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
    • C23C28/04Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material
    • C23C28/042Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material including a refractory ceramic layer, e.g. refractory metal oxides, ZrO2, rare earth oxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/02Methods for coating medical devices

Definitions

  • a process for producing a hydroxyapatite coated substrate comprising the steps of providing a substrate, contacting the substrate with a liquid solution, and heating the substrate and solution with microwave energy to biomimetically grow a hydroxyapatite coating on a surface of the substrate.
  • an implant in another embodiment, includes a substrate and a hydroxyapatite coating grown on the substrate.
  • the hydroxyapatite coating is directly grown on the substrate without any post-treatment.
  • Fig. 1 is a flow diagram of the process of the present invention.
  • Figs. 2A-2D are electron microscope images of hydroxyapatite formation on an edge of surfaces coated by microwave technique.
  • Figs. 3A-3D are electron microscope images of hydroxyapatite formation in the middle of surfaces coated by microwave technique.
  • Figs. 4A and 4B are electron microscope images of hydroxyapatite coatings formed by conventional oven heating and ultrasound methods.
  • Fig. 5 is an electron microscope image of a hydroxyapatite coating made by the process of the present invention.
  • Figs. 6A-6B are electron microscope images of hydroxyapatite coatings formed at high temperatures according to the process of the present invention.
  • Hydroxyapatite occurs naturally in bone and teeth.
  • Synthetic HA (Caio(P0 4 )6(OH) 2 ) therefore is rapidly integrated into natural bone and tissue to increase bonding properties with the implant. Implants made from Ti6A14V and other biocompatible metals alloys and ceramics are particularly compatible with HA coatings.
  • the biomimetic method consists of soaking the implant in a simulated body fluid at an appropriate temperature and pH. For obtaining a biomimetic HA coating on a substrate it requires soaking the substrate.
  • the biomimetic method is used and the temperature of the solution can be, for example, 20-70°C.
  • the method used today is to heat the solution in a conventional oven whereby a conformed coating will be formed after several days, about 4-7. Such a prolonged amount of time it takes to grow the coating in a large scale production could cause a bottle-neck during this process step.
  • nanoparticles are not capable of being used as a coating because there is no adheration possible without post treatment.
  • deposition methods for nanoparticles If nanoparticles would be used to coat an implant surface, which may have a very complicated geometry, the coating process itself would need to be a multi-step process consisting of coating deposition, consisting of several steps, and post-treatment in case of wet-chemical deposition routes. This post-treatment may require quite high temperatures in order to obtain a crystalline HA coating, which also may impact the porosity. High temperatures may lead to changes in the microstructure due to i.e. grain growth, and phase
  • a different approach could be to apply high local temperature to the nanoparticles and melt them in order to form a coating, such as it is used in plasma spraying or laser coatings.
  • coating geometry is a limiting factor and such coatings are often characterized by a poor structural porosity.
  • the present embodiment provides a process 10 for producing a biomimetic HA coated implant.
  • a substrate or base is provided.
  • the substrate can be a ceramic, titanium or a titanium alloy, stainless steel, Cobalt-chrome alloys, wollastonite or bioglass material.
  • Substrates having crystalline, bioactive oxide surfaces selected from the group of Ti0 2 , Si0 2 , Mg0 2 , A10 2 , and Cr0 2 are good candidates. It should also be appreciated that other materials can be chosen depending upon the end product implant and use.
  • the substrate is immersed in a simulated body fluid, such as a phosphate buffer saline (PBS) solution.
  • PBS phosphate buffer saline
  • the solution is prepared with various ion concentrations to mimic the chemical composition of human body fluids, such as blood plasma.
  • the solution can contain calcium and phosphate ions.
  • the coating can be a substituted HA, where the substitution ions can be F, Sr, Mg, Si.
  • the PBS has a pH of 7.1-7.5 at room temperature. Changing the pH value can be a way to address the affinity of doping elements and antibiotics towards the HA.
  • the ion composition and concentrations can be varied in order to achieve different HA structures.
  • the present embodiment uses microwave energy to heat the phosphate buffer saline (PBS) solution instead of conventional oven heating.
  • the microwave catalyzes the HA nucleation and result in faster HA crystal formation.
  • the negatively charged Ti-0 groups of the Ti0 2 attract the positively charged Ca 2+ ions from the body fluid.
  • an amorphous calcium titante layer is built on the surface with a slightly positive charge due to the Ca 2+ ions.
  • This layer attracts the negatively charged phosphate ions towards the surface, resulting in a metastable calcium phosphate layer, which transforms into a thermodynamically more favorable crystalline structure.
  • Increased kinetic energy from the microwave process results in a faster binding occurrence between the ions and possibly an increased number of binding sites, both from the solution and the substrate surface.
  • the substrate soaking in the ionic solution is irradiated in a microwave cell.
  • the irradiation temperature is in the range of about 40 to about 250 C°, although the optimal coating temperature is within the range of about 40 to about 90°C.
  • the temperature is a variable for the desired coating structure and allows tuning coating porosity as well as morphology and may thus be varied in cycles, with dynamic or linear ramping.
  • the microwave process allows for quick temperature changes within seconds.
  • HA coatings have shown promising potential to be used as a drug vehicle for local drug delivery at the implantation site. Co-precipitation of HA and drug on the surface can be obtained when the temperature is below about 90 °C when chemical structures, i.e.
  • carboxyl groups in antibiotics bind to calcium ions in the HA, or when ions from both PBS and the drug simultaneously are incorporated by co-precipitation.
  • the coating thickness, porosity and morphology can be varied to achieve differently designed drug delivery profiles, such as; different releasing times with initial burst effect and/or controlled long term release and/or cycled release.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Ceramic Engineering (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A process for producing a biomimetic hydroxyapatite coated substrate comprising the steps of providing a substrate, contacting the substrate with a liquid solution, and heating the substrate and solution with microwave energy to biomimetically grow a hydroxyapatite coating directly on a surface of the substrate.

Description

HYDROXYAPATITE COATING PROCESS USING
MICROWAVE TECHNOLOGY
Inventors:
ULRIKA BROHEDE MIRJAM LILJA
RELATED APPLICATION DATA
This application is a PCT International Application claiming priority of U.S. Provisional Application No. 61/678,457, filed August 1, 2012.
TECHNICAL FIELD AND INDUSTRIAL APPLICABILITY
[0001] The present embodiment relates to a process using microwave technology for coating implants with a biomimetically grown hydroxyapatite coating.
SUMMARY
[0002] In one embodiment, a process for producing a hydroxyapatite coated substrate comprising the steps of providing a substrate, contacting the substrate with a liquid solution, and heating the substrate and solution with microwave energy to biomimetically grow a hydroxyapatite coating on a surface of the substrate.
[0003] In another embodiment, an implant includes a substrate and a hydroxyapatite coating grown on the substrate. The hydroxyapatite coating is directly grown on the substrate without any post-treatment.
[0004] These and other objects, features, aspects, and advantages of the present disclosure will become more apparent from the following detailed description of the preferred embodiments relative to the accompanied drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
[0005] Fig. 1 is a flow diagram of the process of the present invention.
[0006] Figs. 2A-2D are electron microscope images of hydroxyapatite formation on an edge of surfaces coated by microwave technique. [0007] Figs. 3A-3D are electron microscope images of hydroxyapatite formation in the middle of surfaces coated by microwave technique.
[0008] Figs. 4A and 4B are electron microscope images of hydroxyapatite coatings formed by conventional oven heating and ultrasound methods.
[0009] Fig. 5 is an electron microscope image of a hydroxyapatite coating made by the process of the present invention.
[0010] Figs. 6A-6B are electron microscope images of hydroxyapatite coatings formed at high temperatures according to the process of the present invention.
DETAILED DESCRIPTION
[0011] Hydroxyapatite (HA) coated implants for orthopedic and dental
reconstruction are widely used. Hydroxyapatite occurs naturally in bone and teeth.
Synthetic HA (Caio(P04)6(OH)2) therefore is rapidly integrated into natural bone and tissue to increase bonding properties with the implant. Implants made from Ti6A14V and other biocompatible metals alloys and ceramics are particularly compatible with HA coatings.
[0012] Numerous techniques are known for coating implant substrates with HA including plasma spraying, dip coating, sputter deposition, electrophoretic deposition and sol-gel synthesis. All these conventional techniques have numerous disadvantages. For example, plasma sprayed HA, the only viable commercially available HA coating process on the market, is a high temperature process resulting in a thick and dense coating with non-uniform coverage and poor substrate adhesion.
[0013] The biomimetic method consists of soaking the implant in a simulated body fluid at an appropriate temperature and pH. For obtaining a biomimetic HA coating on a substrate it requires soaking the substrate. The biomimetic method is used and the temperature of the solution can be, for example, 20-70°C. The method used today is to heat the solution in a conventional oven whereby a conformed coating will be formed after several days, about 4-7. Such a prolonged amount of time it takes to grow the coating in a large scale production could cause a bottle-neck during this process step.
[0014] Researchers have put effort into finding ways to increase the number of nucleation sites and/or to change HA composition, not with the focus of speeding up the process, but to increase the coating adhesion and/or to change the texture and
morphology in the coating. The use of microwave irradiation to form HA nanoparticles in a biomimetic solution has been explored. However, the particles are not capable of being used as a coating because there is no adheration possible without post treatment. There are numerous possible deposition methods for nanoparticles. If nanoparticles would be used to coat an implant surface, which may have a very complicated geometry, the coating process itself would need to be a multi-step process consisting of coating deposition, consisting of several steps, and post-treatment in case of wet-chemical deposition routes. This post-treatment may require quite high temperatures in order to obtain a crystalline HA coating, which also may impact the porosity. High temperatures may lead to changes in the microstructure due to i.e. grain growth, and phase
transformation. See Lilja M. et al. "Drug Loading and Release of Tobramycin from Hydroxyapatite Coated Fixation Pins," J Mater Sci Mater Med in press 10.1007/sl0556- 013-4979-1 (2013).
[0015] A different approach could be to apply high local temperature to the nanoparticles and melt them in order to form a coating, such as it is used in plasma spraying or laser coatings. In that case, coating geometry is a limiting factor and such coatings are often characterized by a poor structural porosity.
[0016] In order to overcome the prior art HA coating methodologies, the present disclosure employs microwave technology for achieving a faster, more controllable and stable/reliable process for biomimetically grown hyroxyapatite coatings than what are currently available and furthermore allows for tailoring of the HA coating structure. The biomimetic coating process of the present embodiments only requires a bioactive surface and the buffer solution to form a coating. No post-treatment is required to achieve a crystalline, uniform coating. A biomimetically grown HA coating contributes towards an enhanced bone bonding capability and increases bone in-growth towards the implant surface. The microwave heating reduces the process significantly. Process time and cost are reduced and coating quality and flexibility are increased.
[0017] Referring to Fig. 1, the present embodiment provides a process 10 for producing a biomimetic HA coated implant. In a first step 12, a substrate or base is provided. For example, the substrate can be a ceramic, titanium or a titanium alloy, stainless steel, Cobalt-chrome alloys, wollastonite or bioglass material. Substrates having crystalline, bioactive oxide surfaces selected from the group of Ti02, Si02, Mg02, A102, and Cr02 are good candidates. It should also be appreciated that other materials can be chosen depending upon the end product implant and use.
[0018] In the next step 14, the substrate is immersed in a simulated body fluid, such as a phosphate buffer saline (PBS) solution. The solution is prepared with various ion concentrations to mimic the chemical composition of human body fluids, such as blood plasma. The solution can contain calcium and phosphate ions. Moreover, the coating can be a substituted HA, where the substitution ions can be F, Sr, Mg, Si. Optimally, the PBS has a pH of 7.1-7.5 at room temperature. Changing the pH value can be a way to address the affinity of doping elements and antibiotics towards the HA. Also, the ion composition and concentrations can be varied in order to achieve different HA structures.
[0019] As discussed supra, the present embodiment uses microwave energy to heat the phosphate buffer saline (PBS) solution instead of conventional oven heating. The microwave catalyzes the HA nucleation and result in faster HA crystal formation. The negatively charged Ti-0 groups of the Ti02 attract the positively charged Ca2+ ions from the body fluid. As a result of this ionic interaction, an amorphous calcium titante layer is built on the surface with a slightly positive charge due to the Ca2+ ions. This layer attracts the negatively charged phosphate ions towards the surface, resulting in a metastable calcium phosphate layer, which transforms into a thermodynamically more favorable crystalline structure. Increased kinetic energy from the microwave process results in a faster binding occurrence between the ions and possibly an increased number of binding sites, both from the solution and the substrate surface.
[0020] As shown in step 16, the substrate soaking in the ionic solution is irradiated in a microwave cell. Preferably, the irradiation temperature is in the range of about 40 to about 250 C°, although the optimal coating temperature is within the range of about 40 to about 90°C. The temperature is a variable for the desired coating structure and allows tuning coating porosity as well as morphology and may thus be varied in cycles, with dynamic or linear ramping. The microwave process allows for quick temperature changes within seconds. [0021] In addition, HA coatings have shown promising potential to be used as a drug vehicle for local drug delivery at the implantation site. Co-precipitation of HA and drug on the surface can be obtained when the temperature is below about 90 °C when chemical structures, i.e. carboxyl groups in antibiotics, bind to calcium ions in the HA, or when ions from both PBS and the drug simultaneously are incorporated by co-precipitation. The coating thickness, porosity and morphology can be varied to achieve differently designed drug delivery profiles, such as; different releasing times with initial burst effect and/or controlled long term release and/or cycled release.
[0022] Initial experiments show a monolayer of HA forming within about 1 to about 4 hours on the substrate surface, where the conventional method needed 1-3 days for full substrate coverage. The substrates are PVD coated Titanium grade 5 turned discs, where the coating is an anatase dominated Ti02 with a coating thickness of about 500nm. Figs. 2A- 2D are electron microscope images of HA formation on the edge of the disc after being in a microwave temperature controlled 3 ml Dulbecco's PBS (D8662, Sigma Aldrich) bath at 60°C for 1 hour (Fig. 2A); 60°C for 4 hours (Fig. 2B); 60°C for 96 hours (Fig. 2C) and 120°C for 1 hour (Fig. 2D). The HA crystals form on the Ti02 surface as a result of the interaction between the slightly negative charged anatase surface and the ions in the phosphate buffered saline (PBS) solution, as described above. Longer immersion time of the Ti02 coated substrates in PBS at 60°C does not lead to increased HA crystals formation on the Ti02 surface due to saturation of the HA, i.e., there are no additional binding sites available.
[0023] Figs. 3 A- 3D are electron microscope images of HA formation in the middle of the disc in an microwave temperature controlled 3 ml PBS bath at 60°C for 1 hour (Fig. 3A); 60°C for 4 hours (Fig. 3B); 60°C for 96 hours (Fig. 3C) and 120°C for 1 hour (Fig. 3D). Formation of the HA crystals is described above. The amount of HA crystals observed in the middle of the disc is decreased compared to the edge as a result of too few ions in the solution. Nucleation starts at preferred sites close to the edge.
[0024] Fig. 4A illustrates a rolled Ti02 surface soaked in a PBS bath and heated in an oven for lhour at 60 °C. The sample was placed in plastic tubes containing 40 ml of Dulbecco's Phosphate Buffered Saline (PBS), which was kept in a controlled temperature of 60 °C in a Termak's (Termak, Norway) laboratory oven for 1 hour. After removal from the PBS, the samples were carefully rinsed in deionized water and left to dry in air. Formation of the HA crystals on the Ti02 surface is described above.
[0025] Fig. 4B illustrates a rolled Ti02 surface soaked in ultrasound heated PBS for 1 hour at 60°C. As described above, the sample was kept in a plastic tube filled with 40ml PBS and kept for 1 hour at 60°C in a Branson (Danbury, CT) ultrasonic bath. The temperature of the PBS solution was measured with a thermometer. As it can be seen from the SEM image, the Ti02 surface is coated with a network of HA crystals, having a much smaller diameter and distance to each other, i.e. a denser structure, compared to the samples presented in Fig. 2 and 3. Nucleation and growth of HA crystals, and thus coatings, can obviously be tuned by selecting the energy and frequency to heat the PBS.
[0026] Fig. 5 illustrates a turned Ti02 surface heated for 1 hour at 60°C in a microwave according to the process of the present invention. As can be seen from the electron microscope image, a high density of HA crystals on the Ti02 surface are visible, compared to Fig. 4a. Applying microwave for heating the PBS contributes towards catalyzing HA nucleation and growth of the crystals, as described above. The surface topography on the rolled and turned disc does not affect the HA nucleation time in the same order of time as the effect of sonication does, i.e. on the present time scale the topography has no or only a minor contribution to HA formation time.
[0027] Figs. 6A and 6B illustrate HA formation at high temperature (150°C) and for long periods of time, for example, 15 hours. This experiment was made to investigate if there could be seen a significant difference on nucleation or to extract more ions from the PBS solution. The result instead showed that there is probably an optimum regarding temperature and ionic concentration for the set-up. The image shows a cluster of formed HA on the first nucleation site close to the edge of the disc. The structure changes more by variation of wave-length for example, within the range of 5 x 10 8 - 5 x 1011 Hz for microwave and 20 x 103- 20 x 107 Hz for ultrasound, than time and temperature.
[0028] Referring again to Figs 4A-4C, at 60°C HA is nucleated at the surface.
However, a limited amount of HA is formed. This can be due to the lack of ions available in the amount of solution. [0029] Referring again to Figs 2D, 3D, 6A and 6B, at the higher temperatures spheres are formed on the surface, due to preferred growth at initial nucleation sites. More HA is nucleated at the center of the disc as compared to the edge.
[0030] In summary, compared to the standard HA coating methods, HA formation according to the process of the present invention occurs earlier and faster.
[0031] Itemized list of embodiments:
1. A process for producing a hydroxyapatite coated substrate, comprising the steps of:
providing a substrate;
contacting the substrate with a liquid solution;
heating the substrate and solution with energy means for growing a hydroxyapatite coating directly on a surface of the substrate.
2. The process according to item 1, characterized in that the energy means comprises microwave energy.
3. The process according to item 1 or 2, characterized in that the substrate is a metal selected from the group of Ti02, Si02, Mg02, A102, and Cr02 .
4. The process according to any one of items 1 to 3, characterized in that the coating is an ion substituted hydroxyapatite.
5. The process according to any one of items 1 to 4, characterized in that the substituted ions are selected from the group of F, Sr, Si and Mg.
6. The process according to any one of items 1 to 5, characterized in that the step of contacting the article with a solution comprises soaking the article in a phosphate buffer saline solution. 7. The process according to any one of items 1 to 6, characterized in that the solution contains calcium and phosphate ions.
8. The process according to any one of items 1 to 7, characterized in that the step of heating the substrate and solution comprises heating to a temperature of about 40 to about 250°C.
9. The process according to any one of items 1 to 8, characterized in that the heating temperature is within the range of about 40to about 90°C.
10. The process according to any one of items 1 to 9, comprising the step of altering the heating temperature to control porosity and morphology of the
hydroxyapatite coating.
11. The process according to any one of items 1 to 10, characterized in that the liquid solution is a biomimetic solution and the step of growing the coating comprises biomimetically growing the hydroxyapatite on the substrate.
12. The process according to any one of items 1 to 11, characterized in that the biomimetic coating is grown directly on the substrate without any post treatment.
13. An implant made according to the process of any one of items 1-12.
14. An implant comprising:
a substrate; and
a hydroxyapatite coating grown on said substrate, wherein said hydroxyapatite is directly grown on said substrate without any post-treatment.
15. The implant according to item 14, characterized in that the substrate is a metal selected from the group of Ti02, Si02, Mg02, A102, and Cr02 . 16. The implant according to item 14 or 15, characterized in that the coating is an ion substituted hydroxyapatite.
17. The implant according to any one of items 14-16, characterized in that the substituted ions are selected from the group of F, Sr, Si and Mg.
18. The implant according to any one of items 14-17, characterized in that the coating is a biomimetic hydroxyapatite coating.
[0032] Although the present disclosure has been described in relation to particular embodiments thereof, many other variations and modifications and other uses will become apparent to those skilled in the art. It is preferred therefore, that the present embodiment be limited not by the specific disclosure herein, but only by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A process for producing a hydroxyapatite coated substrate, comprising the steps of:
providing a substrate; contacting the substrate with a liquid solution; heating the substrate and solution with microwave energy; and growing a hydroxyapatite coating on a surface of the substrate.
2. The process of claim 1, wherein the substrate is a metal selected from the group of Ti02, Si02, Mg02, A102, and Cr02 .
3. The process of claim 1, wherein the coating is an ion substituted hydroxyapatite.
4. The process of claim 3, wherein the substituted ions are selected from the group of F, Sr, Si and Mg.
5. The process of claim 1, wherein the step of contacting the article with a solution comprises soaking the article in a phosphate buffer saline solution.
6. The process of claim 5, wherein the solution contains calcium and phosphate ions.
7. The process of claim 1, wherein the step of heating the substrate and solution comprises heating to a temperature of about 40 to about 250°C.
8. The process of claim 7, wherein the heating temperature is within the range of about 40 to about 90°C.
9. The process of claim 8, further comprising the step of altering the heating temperature to control porosity and morphology of the hydroxyapatite coating.
10. The process of claim 1, wherein the liquid solution is a biomimetic solution and the step of growing the coating comprises biomimetically growing the hydroxyapatite on the substrate.
11. The process of claim 10, wherein the biomimetic coating is grown directly on the substrate without any post treatment.
12. An implant comprising:
a substrate; and
a hydroxyapatite coating grown on said substrate, wherein said
hydroxyapatite is directly grown on said substrate without any post-treatment.
13. The implant of claim 12, wherein the substrate is a metal selected from the group of Ti02, Si02, Mg02, A102, and Cr02 .
14. The implant of claim 12, wherein the coating is an ion substituted hydroxyapatite.
15. The implant of claim 14, wherein the substituted ions are selected from the group of F, Sr, Si and Mg.
16. The implant of claim 12, wherein the coating is a biomimetic
hydroxyapatite coating.
17. A process for producing a hydroxyapatite coated substrate, comprising the steps of:
providing a substrate;
contacting the substrate with a liquid solution;
heating the substrate and solution with energy for growing a hydroxyapatite coating directly on a surface of the substrate.
18. The process of claim 17, wherein the energy comprises microwave energy.
19. The process of claim 18, wherein the substrate is a metal selected from the group of Ti02, Si02, Mg02, A102, and Cr02 .
20. The process of claiml9, wherein the coating is an ion substituted hydroxyapatite.
21. The process of claim 20, wherein the substituted ions are selected from the group of F, Sr, Si and Mg.
22. The process of claim 21, wherein the step of contacting the article with a solution comprises soaking the article in a phosphate buffer saline solution.
23. The process of claim 22, wherein the solution contains calcium and phosphate ions.
24. The process of claim 23, wherein the step of heating the substrate and solution comprises heating to a temperature of about 40 to about 250°C.
25. The process of claim 24, wherein the heating temperature is within the range of about 40 to about 90°C.
26. The process of claim 17, wherein the liquid solution is a biomimetic solution and the step of growing the coating comprises biomimetically growing the hydroxyapatite on the substrate.
27. The process of claim 26, wherein the biomimetic coating is grown directly on the substrate without any post treatment.
28. The process of claim 17, further comprising the step of altering the heating temperature to control porosity and morphology of the hydroxyapatite coating.
PCT/IB2013/002181 2012-08-01 2013-07-31 Hydroxyapatite coating process using microwave technology WO2014020446A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261678457P 2012-08-01 2012-08-01
US61/678,457 2012-08-01

Publications (2)

Publication Number Publication Date
WO2014020446A2 true WO2014020446A2 (en) 2014-02-06
WO2014020446A3 WO2014020446A3 (en) 2014-03-20

Family

ID=49585434

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/002181 WO2014020446A2 (en) 2012-08-01 2013-07-31 Hydroxyapatite coating process using microwave technology

Country Status (1)

Country Link
WO (1) WO2014020446A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015126344A1 (en) * 2014-02-24 2015-08-27 Gumusderelioglu Menemse A method for producing a hap (hydroxyapatite)/boron-doped hap and developing composite tissue scaffolds
CN105063618A (en) * 2015-08-22 2015-11-18 山东建筑大学 Method for preparing hydroxyapatite film layer on magnesium alloy surface
WO2015187110A3 (en) * 2014-06-06 2016-01-28 Ercan Durmus Coating dental and orthopedic implant surfaces with bioactive material
US10925997B2 (en) * 2016-10-26 2021-02-23 Biointelligence Systems S.L. Bone bioactive composition and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10287411A (en) * 1997-04-07 1998-10-27 Agency Of Ind Science & Technol Formation of hydroxyapatite film
WO2004043333A2 (en) * 2002-11-14 2004-05-27 Prochon Biotech Ltd. Bone enhancing composite
EP2042200A1 (en) * 2006-06-19 2009-04-01 Kyoto University Method of producing bioactive complex material
EP2773389A4 (en) * 2011-10-31 2015-09-16 Univ Toledo METHOD FOR MODIFYING SURFACES FOR BETTER OSTEOINTEGRATION

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LILJA M. ET AL.: "Drug Loading and Release of Tobramycin from Hydroxyapatite Coated Fixation Pins", J MATER SCI MATER MED, 2013

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015126344A1 (en) * 2014-02-24 2015-08-27 Gumusderelioglu Menemse A method for producing a hap (hydroxyapatite)/boron-doped hap and developing composite tissue scaffolds
WO2015187110A3 (en) * 2014-06-06 2016-01-28 Ercan Durmus Coating dental and orthopedic implant surfaces with bioactive material
CN105063618A (en) * 2015-08-22 2015-11-18 山东建筑大学 Method for preparing hydroxyapatite film layer on magnesium alloy surface
US10925997B2 (en) * 2016-10-26 2021-02-23 Biointelligence Systems S.L. Bone bioactive composition and uses thereof

Also Published As

Publication number Publication date
WO2014020446A3 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
Zhang et al. Synthesis and characterization of sol–gel hydroxyapatite coatings deposited on porous NiTi alloys
Sato et al. Enhanced osteoblast adhesion on hydrothermally treated hydroxyapatite/titania/poly (lactide-co-glycolide) sol–gel titanium coatings
López et al. Growth of crystalline hydroxyapatite thin films at room temperature by tuning the energy of the RF-magnetron sputtering plasma
Thian et al. Magnetron co-sputtered silicon-containing hydroxyapatite thin films—an in vitro study
Wen et al. Preparation of calcium phosphate coatings on titanium implant materials by simple chemistry
Liu et al. Bioactive calcium phosphate coating formed on micro-arc oxidized magnesium by chemical deposition
Surmenev et al. Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis–a review
Chen et al. Study on the formation of an apatite layer on NiTi shape memory alloy using a chemical treatment method
Keshmiri et al. Apatite formation on TiO2 anatase microspheres
Paital et al. Wettability and kinetics of hydroxyapatite precipitation on a laser-textured Ca–P bioceramic coating
Kim et al. In vitro dissolution and mechanical behavior of c-axis preferentially oriented hydroxyapatite thin films fabricated by pulsed laser deposition
Mozafari et al. Thin films for tissue engineering applications
Pisarek et al. Effect of two-step functionalization of Ti by chemical processes on protein adsorption
WO2014020446A2 (en) Hydroxyapatite coating process using microwave technology
Lindahl et al. Biomimetic calcium phosphate coating of additively manufactured porous CoCr implants
Li et al. Structure, composition and morphology of bioactive titanate layer on porous titanium surfaces
Durham III et al. Deposition, heat treatment and characterization of two layer bioactive coatings on cylindrical PEEK
Adawy et al. An efficient biomimetic coating methodology for a prosthetic alloy
Assis et al. Comparison of crystallinity between natural hydroxyapatite and synthetic cp-Ti/HA coatings
Lilja et al. Influence of microstructure and chemical composition of sputter deposited TiO2 thin films on in vitro bioactivity
Hu et al. One-step modification of nano-hydroxyapatite coating on titanium surface by hydrothermal method
Wang et al. Effect of heat-treatment atmosphere on the bond strength of apatite layer on Ti substrate
Jonauskė et al. Sol-gel derived calcium hydroxyapatite thin films on 316L stainless steel substrate: Comparison of spin-coating and dip-coating techniques
Ko et al. Effect of Mg ion on formation of bone-like apatite on the plasma modified titanium surface
Forsgren et al. A novel method for local administration of strontium from implant surfaces

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13792065

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13792065

Country of ref document: EP

Kind code of ref document: A2